Non-invasive, personalized diagnosis of coronary artery disease

The FFR-CT-based technology developed by HEMOLENS allows for a detailed anatomical and functional evaluation of coronary arteries.

FFR-CT is an innovative non-invasive diagnostic tool for examining coronary artery disease severity

The FFR-CT-based technology developed by HEMOLENS allows for a detailed anatomical and functional evaluation of coronary arteries using computational fluid dynamic principles.

HEMOLENS’ FFR-CT-based technology analyzes data from two non-invasive diagnostic methods:

  • Coronary computed tomography angiography (CCTA)
  • Continuous non-invasive blood pressure (CNBP) monitoring

Benefits of HEMOLENS technology

Capability for testing more patients with the same infrastructure

Reduced hospitalizations and related costs

Fast and safe diagnostic method

Reduced risk and improved patient comfort

Non-invasive tool to obtain quantitative functional results of stenosis severity

Improved planning of invasive procedures based on functional FFR-CT data

Reduced number of unnecessary invasive catheterizations and coronary angiographies

What are the steps of the FFR-CT-based HEMOLENS diagnostic procedure?


  • Log in to the Hemolens platform.
  • Enter patient history.
  • Upload CT scans (CCTA).
  • Upload the CNBP signal.


  • Generate a 3D reconstruction the patient’s coronary artery network.
  • Produce simulations of blood flow in the 3D coronary model on the basis of the CT iamges and CNBP measurements.


  • Multi-point interactive measurements of virtual FFR, combined with distance measurements for each vessel segment (vessels above 1.8mm).

Our pipeline

Cardiology & Cardio-radiology

A technology for healthcare providers to accurately diagnose patients with suspected ischemic heart disease.


Assessment of cerebral blood flow and brain perfusion as a significant diagnostic parameter in the diagnosis and treatment of stroke and brain aneurysms (in development).


Evaluation of hepatic, renal and cerebral blood flow and angiogenesis levels as a tool in planning optimal radio- and chemotherapy (in development).


Evaluation of pulmonary blood flow as an important diagnostic factor in the prevention and diagnostics of lung diseases (in development).


Assessment of blood flow in large vessels such as the aorta or femoral artery is an important prognostic of thrombotic lesions and a useful tool in planning the surgical treatment of embolisms (in development).

Certificates and standards

Quality Management System certificate of compliance with European Standard PN-EN ISO 13485:2016 and Medical Device Certificate in accordance with Directive 93/42/EEC.

We use cookies and similar technologies, incl. for the purposes of: providing services, advertising, statistics. Using the site without changing your browser settings means that they will be placed on your end device. Remember that you can always change these settings.